Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To test the current standard of care (SOC) treatment for laparoscopic cholecystectomy with a group receiving SOC + additional perioperative analgesics in terms of postoperative abilities, PONV, pain and discharge time from the PACU

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hvidovre University Hospital
• Treatments: Droperidol; Esketamine; Gabapentin; Ketamine; Lidocaine

Criteria

Inclusion Criteria:

• Elective laparoscopic cholecystectomy

• Age above 18 years

• Written informed consent

• ASA class I-III

Exclusion Criteria:

• Planned abdominal cholecystectomy

• Intraoperative conversion of laparoscopic to laparotomic cholecystectomy

• Allergy to part of the treatment regimens

• Previous reactions to opioids (nausea, cognition)